| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |